Loading…
Loading…
See exactly how IBD's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IBD and 80,000+ other tickers.
The Inspire Corporate Bond ETF primarily invests in high-quality debt securities issued by large American corporations that are selected for their inspiring and biblically aligned principles. This fund aims to mirror the performance outcomes of the Inspire Corporate Bond Index.
SPY003 met its primary endpoint with a statistically significant reduction of 10.0 points (p
BOISE, Idaho, Aug. 25, 2026 /PRNewswire/ -- Inspire Investing is pleased to announce that the Inspire Corporate Bond ETF (NYSE: IBD) has been awarded a 5-star Overall Morningstar Rating™ for the 5-year period out of 155 Corporate Bond funds as of 7/31/26. Morningstar's rating system evaluates funds based on their risk-adjusted returns relative to category peers, with the top 10% of funds in each category receiving a 5-star rating.
SYRE expands into HS with SPY772, testing whether dual-pathway inhibition can strengthen outcomes in SKYLIGHT.
Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
IBD's Alexis Garcia and Ed Carson preview key upcoming earnings reports from Eli Lilly, Sandisk and SpaceX. Check out our daily newsletter!